The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)

BACKGROUND: Between 2000–2007, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) delivered more than 1.9 billion treatments to nearly 600 million individuals via annual mass drug administration (MDA) of anti-filarial drugs (albendazole, ivermectin, diethylcarbamazine) to all at-risk for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chu, Brian K., Hooper, Pamela J., Bradley, Mark H., McFarland, Deborah A., Ottesen, Eric A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2879371/
https://ncbi.nlm.nih.gov/pubmed/20532228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000708
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares